BWL
CYTK icon

Bogart Wealth LLC’s Cytokinetics CYTK Stock Holding History

Bogart Wealth LLC’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
22
+6
+38% +$431 ﹤0.01% 1478
2026
Q1 		$1.05K Buy
+16
New +$1.02K ﹤0.01% 1432
2025
Q3 		– Sell
-12
Closed -$396 – 1551
2025
Q2 		$396 Buy
+12
New +$417 ﹤0.01% 1379

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bogart Wealth LLC's CYTK Position: Q2 2026 in Review

Bogart Wealth LLC increased its Cytokinetics (CYTK) stake by 38% in Q2 2026, buying an estimated $431 and bringing the position to 22 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Bogart Wealth LLC first reported a position in CYTK in Q2 2025 and has held it in 3 quarters since. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Bogart Wealth LLC held 22 shares of Cytokinetics worth $1.87K as of Q2 2026.
  • Bogart Wealth LLC bought 6 Cytokinetics shares in Q2 2026, an estimated $431.
  • Cytokinetics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1478 holding.
  • Bogart Wealth LLC first reported a position in Cytokinetics in Q2 2025 and has held it in 3 quarters since.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.